BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia - BridgeBio Pharma ( NASDAQ:BBIO )
PALO ALTO, Calif., Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- BridgeBio Pharma, Inc.
| Ticker |
Sentiment |
Impact |
|
BBIO
|
Neutral
|
10 %
|
|
META
|
Neutral
|
3 %
|
